Direct oral anticoagulants (DOACs) are associated with better outcomes than warfarin among patients with valvular atrial fibrillation (AF), according to a study published on March 30, 2021 in the Annals of Internal Medicine.
The list of medication options to treat patients who have diabetes grows continually longer and longer. A new clinical practice review article published April 1 by Rita Rastogi Kalyani, MD, in The New England Journal of Medicine (NEJM), distills the newest trial results and guidelines into a systematic approach for the treatment of patients with diabetes.
New clinical guidelines promote shorter courses of antibiotics for the treatment of uncomplicated cases of pneumonia, urinary tract infection, cellulitis, COPD exacerbations, and acute bronchitis, according to updated recommendations from the American College of Physicians.
On March 29, CDC revised its list of conditions that put an individual at high risk for severe COVID-19 disease, meaning the patient may require hospitalization, intensive care, a ventilator to help with breathing, or could even die.
It is well established that long-term use of high doses of NSAIDs can cause kidney injury, especially in older adults. This association has been criticized, however, because it is based only on serum creatinine-based glomerular filtration rate (GFR) estimates. A recent study published in the March issue of the Journal of the American Geriatrics Society investigated the association of NSAID use with kidney damage in older adults using multiple kidney health measures.